Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 7 May 2009, Vol. 113, No. 19, pp. 4627-4636.
Prepublished online as a Blood First Edition Paper on March 3, 2009; DOI 10.1182/blood-2008-10-183467.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2008-10-183467v1
113/19/4627    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, L.
Right arrow Articles by Ford, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, L.
Right arrow Articles by Ford, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 9, 2008
Accepted February 9, 2009

BAFF-R promotes cell proliferation and survival through interaction with IKK{beta} and NF-{kappa}B/c-Rel in the nucleus of normal and neoplastic B lymphoid cells

Lingchen Fu, Yen-Chiu Lin-Lee, Lan V. Pham, Archito T. Tamayo, Linda C. Yoshimura, and Richard J. Ford*

Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States

* Corresponding author; email: rford{at}mdanderson.org.

BLyS and its major receptor BAFF-R, have been shown to be critical for development and homeostasis of normal B-lymphocytes, and for cell growth and survival of neoplastic B-lymphocytes, but the biologic mechanisms of this ligand/receptor-derived intracellular signaling pathway(s) have not been completely defined. We have discovered that the BAFF-R protein was present in the cell nucleus, in addition to its integral presence in the plasma membrane and cytoplasm, in both normal and neoplastic B-cells. BAFF-R interacted with histone H3 and IKK{beta} in the cell nucleus, enhancing histone H3 phosphorylation through IKK{beta}. Nuclear BAFF-R was also associated with NF-{kappa}B/c-Rel and bound to NF-{kappa}B targeted promoters including BLyS, CD154, Bcl-xL, IL-8, and Bfl-1/A1, promoting the transcription of these genes. These observations suggested that in addition to activating NF-{kappa}B pathways in the plasma membrane, BAFF-R also promotes normal B-cell and NHL-B cell survival and proliferation by functioning as a transcriptional regulator through a chromatin remodeling mechanism(s) and NF-{kappa}B association. Our studies provide an expanded conceptual view of the BAFF-R signaling, that should contribute a better understanding of the physiologic mechanisms involved in normal B-cell survival and growth, as well as in the pathophysiology of aggressive B-cell malignancies and autoimmune diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
W. N. Khan
B Cell Receptor and BAFF Receptor Signaling Regulation of B Cell Homeostasis
J. Immunol., September 15, 2009; 183(6): 3561 - 3567.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020